Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Eazymedi Oy
OY
Dissolved
Y-tunnus 3256637-5
Mellunmäentie 24-B23
General medical practice activities · NACE 8621
Est. 2021
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
EUR 257K
+19% vs 2023
EBITDA margin
40.8%
+97% vs 2023
Equity ratio
67.9%
Financial strength
Net profit 2024
EUR 68K
+175% vs 2023
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
EUR 257K
+19%
EBITDA
EUR 105K
+97%
Net profit
EUR 68K
+175%
Total assets
EUR 217K
+4%
Equity
EUR 147K
+87%
Employees
—
—
Company information
Legal name
Eazymedi Oy
Y-tunnus number
3256637-5
Legal form
Osakeyhtiö
NACE code
8621 · General medical practice activities
Founded
26. joulukuuta 2021
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Terveyskeskus- ja vastaavat yleislääkäripalvelut
Contact
Address
Mellunmäentie 24-B23
Phone
+3580413116611
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Helsinki
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
EUR thousands
Item
2022
2023
2024
Revenue
156
216
257
Staff expenses
−49
−88
−100
EBITDA
87
53
105
Depreciation & amort.
−13
−21
−16
EBIT
74
32
89
Net financials
−0
−1
−2
Profit before tax
74
31
87
Tax
15
6
18
Net profit
59
25
68
Balance sheet
EUR thousands
Item
2022
2023
2024
Total assets
117
208
217
Equity
59
79
147
Long-term debt
—
18
0
Short-term debt
59
129
70
Total debt
59
129
70
Financial ratios
5-year trend
EBITDA margin
40.8%
This company
15.8%
Market median
+158% vs market
2022
2024
Equity ratio
67.9%
This company
38.2%
Market median
+78% vs market
2022
2024
Return on equity
46.5%
This company
18.4%
Market median
+153% vs market
2022
2024
Net profit margin
26.7%
This company
8.1%
Market median
+230% vs market
2022
2024
Asset turnover
1.18×
This company
1.12×
Market median
+5% vs market
2022
2024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
HA
Husein Abdulkadir Mohamud
Chief Executive Officer
Chief Executive Officer
2022
KA
Khaliif Abdirashid Awad
Deputy Member
Deputy Member
2022
Former (1)
SS
Serdar Simsek
Deputy Member
Deputy Member
2022 – 2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Eazymedi Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Husein Abdulkadir Mohamud
Chief Executive Officer
0 companies
Khaliif Abdirashid Awad
Deputy Member
0 companies
Serdar Simsek
Deputy Member
0 companies